- Home
- USNA vs SIGA Comparison
USNA vs SIGA Comparison
Compare USNA & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USNA
- SIGA
- Stock Information
- Founded
- USNA 1992
- SIGA 1995
- Country
- USNA United States
- SIGA United States
- Employees
- USNA N/A
- SIGA N/A
- Industry
- USNA Medicinal Chemicals and Botanical Products
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- USNA Health Care
- SIGA Health Care
- Exchange
- USNA Nasdaq
- SIGA Nasdaq
- Market Cap
- USNA 565.2M
- SIGA 515.1M
- IPO Year
- USNA 1996
- SIGA 1997
- Fundamental
- Price
- USNA $29.43
- SIGA $6.61
- Analyst Decision
- USNA Hold
- SIGA
- Analyst Count
- USNA 1
- SIGA 0
- Target Price
- USNA $36.00
- SIGA N/A
- AVG Volume (30 Days)
- USNA 131.4K
- SIGA 321.4K
- Earning Date
- USNA 07-22-2025
- SIGA 08-05-2025
- Dividend Yield
- USNA N/A
- SIGA 9.08%
- EPS Growth
- USNA N/A
- SIGA N/A
- EPS
- USNA 1.79
- SIGA 0.67
- Revenue
- USNA $899,221,000.00
- SIGA $120,330,310.00
- Revenue This Year
- USNA $13.94
- SIGA N/A
- Revenue Next Year
- USNA $6.51
- SIGA $95.31
- P/E Ratio
- USNA $16.40
- SIGA $9.85
- Revenue Growth
- USNA 2.75
- SIGA N/A
- 52 Week Low
- USNA $23.10
- SIGA $4.95
- 52 Week High
- USNA $45.86
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- USNA 41.67
- SIGA 46.16
- Support Level
- USNA $30.10
- SIGA $6.97
- Resistance Level
- USNA $38.32
- SIGA $7.32
- Average True Range (ATR)
- USNA 1.36
- SIGA 0.21
- MACD
- USNA -0.36
- SIGA -0.04
- Stochastic Oscillator
- USNA 4.61
- SIGA 11.25
About USNA USANA Health Sciences Inc.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.